Overview

Safety and Efficacy of Chronic Hypnotic Use 2

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This proposal will assess risks for transition from therapeutic hypnotic use to abuse in people with insomnia. The investigators will study a hypothesized at-risk sub-population, insomniacs with hyperarousal, and compare two hypnotics, a drug with mood effects, eszopiclone, versus one without mood effects, zolpidem.
Phase:
Phase 4
Details
Lead Sponsor:
Henry Ford Health System
Treatments:
Eszopiclone
Hypnotics and Sedatives
Zolpidem